Search results - 7 results
Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework.
SARS-CoV-2 dissemination across borders using population and wastewater surveillance. The anticipation by WHO and central health care policy entities such as the Center for Disease Control, EMA, and multiple ...
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
support a strategy to eliminate cervical cancer as a public health problem, the World Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical pre-cancerous lesions in 2021. ...
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
triage Uterine Cervical Neoplasms Abstract: In 2020, the World Health Organization (WHO) launched a strategy to eliminate cervical cancer as a public health problem. To support the strategy, the WHO ...
Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol.
HPV assay in a colposcopy referral population. Home-collected FVU (Colli-Pee FV 5020) 1 day before colposcopy (n = 492), at-clinic collected dry vaginal self-samples [multi-Collect Swab (mC; n = 493), ...
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
Michal F; M. Arbyn; Nowakowski, Andrzej Source: BMC Cancer, Volume 23, Issue 1 (2023) Keywords: Atypical Squamous Cells of the Cervix Colposcopy Early Detection of Cancer Female HEALTH POLICY Humans Mass ...
Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
CI: 50.4-95.8) to 99.1 (95% CI: 98.8-99.3), respectively in the population irrespective of HPV status. Higher sensitivity estimates ranging from 60.8% (95% CI: 49.6-70.9) to 75.5% (95% CI: 71.7-78.9) ...
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
Papillomavirus Infections Pilot Projects Point-of-Care Systems Uterine Cervical Neoplasms Abstract: BACKGROUND: Globally, cervical cancer is a major public health problem, with about 604,000 new cases and over ...